Brief: Immupharma Initiates IND-Enabling Program For Kapiglucagon To Treat Diabetes
May 5 (Reuters) - ImmuPharma PLC IMM.L: IMMUPHARMA PLC - INITIATES IND-ENABLING PROGRAM FOR KAPIGLUCAGON TO TREAT DIABETES Source text: ID:nRSE8461Ca Further company coverage: IMM.L ((Reuters.Briefs@thomsonreuters.com;))